Introduction: Diagnostic ambulatory electrocardiogram (AECG) monitoring is widely used for evaluating syncope and collapse, and practice guidelines provide recommendations regarding optimal AECG device selection. However, whether physicians utilize AECGs in accordance with the pertinent guidelines is unclear. This study assessed utilization of AECG monitoring systems for syncope and collapse diagnosis by physicians in the United States.
METHODS
This report comprises findings obtained from physicians of multiple specialties practicing in diverse regions of the United States between mid-2015 to early 2016. The survey was designed to assess "realworld" physician utilization of diagnostic ambulatory ECG monitoring technology in the evaluation of syncope/collapse. The survey was conducted by an independent polling agency (ZS Associates, Evanston, IL, USA). Care was taken to avoid identification of specific device manufacturers. The study was sponsored by Medtronic Inc.; however, sponsor personnel did not participate in recording or interpreting the observations.
Requests to participate were sent to a geographically diverse sample of physicians comprising various specialties. Responding physicians underwent a qualification step prior to being offered to participate in the study. Thereafter, the respondents were accepted for the remainder of the study on a first-come basis within each specialty category and geography. Respondents were deemed to have passed the qualification step if they fulfilled the following criteria: The responding physicians comprised six specialties: (1) emergency department physicians (n = 35), (2) primary care practitioners (n = 35), (3) hospitalists (n = 30), (4) neurologists (n = 30), (5) cardiologists who do not implant devices (nonimplanting cardiologists, n = 34), and (6) cardiologists who do implant devices (Implanting cardiologists, n = 35).
One additional nonimplanting cardiologist failed to complete the survey and data were excluded. Respondents were asked to exclude patients with accidental falls or known epileptic seizures from their responses.
The physicians surveyed encompassed the major geographical regions of the United States: North-East -44%, West -20%, Great Lakes region -18%, South -12%, and South-East -6%. Respondent practice locations were 85% urban and 15% rural.
The number of years in clinical practice for physician respondents ranged from 12 to 20 years. Average duration of practice experience by specialty was similar: ED -16 years; primary care -18 years; hospitalist -12 years; neurology -17 years; and nonimplanting cardiology -20 years; implanting cardiologists -18 years. Respondents received an honorarium for participating.
The statistical analysis plan indicated that sample sizes of approximately 30-35 qualified individuals for each physician subgroup allowed an adequate number of respondents based on the assumption that the test parameters in the larger population of physicians in that specialty follow a normal distribution. Hypothesis testing was conducted using z-test and Student's t-test for proportions and averages, respectively, to ensure that the samples compared belong to equivalent populations. Statistical significance testing was done at the 95% confidence level.
RESULTS
Respondents provided their estimate of the underlying diagnosis for syncope/collapse in their patient population during approximately the prior year as summarized in Table 1 Respondents were asked to estimate the proportion of syncope/collapse patients in whom they utilize AECG monitoring as part Note: †Emergency department respondents were excluded in order to focus on final diagnoses. SD = standard deviation. *See text for explanation of neurological causes. There were no significant differences between specialty groups. of the diagnostic evaluation. Findings varied by specialty, ranging from 25% to 30% for primary care physicians, to in excess of 60% for cardiologists ( Table 2 ). The primary factors that triggered physicians to proceed with AECG diagnostic monitoring were: (1) findings suggesting underlying cardiac disease or channelopathy, (2) a report of palpitations, or (3) physical injury with collapse. Furthermore, among patients with syncope of unknown cause but in whom structural cardiac disease was not suspected, AECG monitoring was most often utilized if the following were found: (1) recurrent collapse events, and/or (2) no abnormalities having been identified despite completion of multiple other tests.
Respondents indicated their preferred AECG monitor technology
given various expected syncope/collapse event frequencies, and these findings are detailed by physician specialty in Table 3 . Approximately 50% of physicians across all specialties reported that despite having access to all AECG technologies described above, they tend to repeat the same wearable AECG technique despite failure to establish a diagnosis on a first attempt. This latter tendency (i.e., reuse of the same technology) ranged from as low as 33% for neurologists to as high as 62% for inpatient cardiologists (Figure 2 ). The principal explanations for repeating the wearable AECG monitoring rather than considering use of ICMs are summarized by specialty in Note: Cards = both device-implanting and nonimplanting cardiologists; ED = emergency department; ICM = insertable cardiac monitors; MCOT = mobile cardiac telemetry; Neuro = neurologist; PCP = primary care providers.
F I G U R E 2
Percentage of physicians by specialty who repeat the same AECG technique in the same patient when first attempt is nondiagnostic. There were no statistically significant differences between specialty groups. Neurologists were further divided into those who work primarily in hospitals (NEURO-IN) and those who are mainly Office based (NEURO-OUT). Similarly, cardiologists were divided into those mainly treating inpatients (CARD-IN) and those mainly treating outpatients (CARD-OUT). AECG = ambulatory electrocardiogram; ER = emergency department; HOSP = hospitalists; PCP = primary care providers In terms of specifics, the 2009 ESC practice guidelines advocate conventional 24-to 48-hour Holter recording systems when the predicted recurrence rate is ≥1/week, and wearable loop recorders for event recurrence intervals of ≤4 weeks. 3 ICMs are favored when the expected time to symptom recurrence is longer. 3, 13 The recent ACCF/AHA/HRS 2017 guideline is less specific, but emphasizes the importance, when possible, of selecting a monitoring system and duration consistent with the expected symptom recurrence frequency. 4 The diagnostic effectiveness of each of the available AECG tools has been assessed in patients in whom syncope is suspected. Thus, for example, the diagnostic utility of wearable loop recorders has been compared to that of Holter monitors. In brief, and not surprisingly, the findings indicate that longer-term loop recorders (generally up to 1 month) provide superior diagnostic capability. 3, [12] [13] [14] [15] Similarly, ICMs, by virtue of offering even more prolonged ambulatory monitoring than do event monitors, have been shown to provide greater diagnostic effectiveness than do wearable loop recorders in this setting. 12, [16] [17] [18] [19] [20] [21] Further, ICMs have proven particularly valuable when conventional diagnostic strategies have failed. For example, the PICTURE registry assessed the diagnostic utility of ICMs in 570 patients considered to have presyncope (7%) or syncope (91%) of unexplained cause. In 2%, the classification was not provided. 22 Prior to ICM implant, patients had undergone a median of 13 diagnostic tests without success. Subsequent to ICM placement, 218 patients (38% of the population) had syncope recurrence during follow-up (average 10 ± 6 months), and in 170 of the 218 cases, the ICM findings were deemed to have guided subsequent management.
DISCUSSION
The PICTURE registry provides an examination of ICM use by clinicians outside of clinical trials. 22 In this regard, the PICTURE registry investigators observed that practitioners tended to utilize ICMs relatively late in their diagnostic evaluations of syncope patients despite ESC guideline recommendations advocating earlier use. 3, 12, 13 The result was that patients often were subjected to a large number of ineffective tests. On the other hand, unlike the current study, the PICTURE registry does not offer insight into the factors that determine physician choices of AECG devices.
Our findings may be considered to reflect the "real world" of clini- of the physicians, the data acquisition process was lengthy and timeconsuming. Consequently, although larger samples would have been preferred, we felt it reasonable to limit the study population to approximately the number needed to achieve the predetermined statistically valid analysis. Second, clinician responses were based on recollection of recent practice rather than prospectively accumulated prospective data. Inevitably, this approach reduces the accuracy of the responses and the overall quality of the data that is being reported. Third, the possibility that certain technologies were not available or not supported by insurance was not addressed. Fourth, it has not been customary for certain medical subspecialties, particularly ED physicians, to prescribe cardiac monitors. However, our findings may be interpreted to suggest that wearable monitors, in particular Holter-type recorders, are often being initiated in the ED (Table 3) . Nevertheless, while ED physicians may be prescribing monitor systems, it is likely that they defer follow-up to other specialties, particularly internal medicine or cardiology. This latter point was not addressed in our survey. Fifth, practitioners from the several noncardiologist specialties may not be expected to be familiar with cardiology-based practice guidelines. Consequently, their responses would not be expected to follow these recommendations. In addition, while neurological conditions are not considered by cardiovascular specialists to be the cause of true syncope, the term was used in this survey in order to capture observations from specialties in which this distinction may not be adhered to rigidly (e.g., primary care providers, ED physicians) and in which previously unsuspected seizures or accidental falls were the cause of collapse. In any event, such findings do offer a "real-world" view (i.e., outside externally required constraints of clinical research trials) of current practice. Sixth, it is likely that there are differences among the patient populations cared for by the various physician specialties surveyed.
These possible differences were not captured in our analysis but may have impacted physician selection of monitoring systems. Finally, clinician responses may have been influenced by the offer of an honorarium. While the source of the honorarium was concealed, the respondent may have assumed that it was derived from one or other AECG manufacturer.
CONCLUSION
In conclusion, in the evaluation of syncope/collapse, most U.S. clinicians appear to employ AECG technology appropriately. Nonetheless, in a substantial minority there remain differences between choice of AECG technology and guideline-based recommendations. 
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